NCT05125978View on ClinicalTrials.gov

Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2026

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Pain, Chronic
Interventions
DRUG

Canadá

Canadá association 1 tablet twice a day

OTHER

Canadá placebo

Placebo of Canadá association 1 tablet twice a day

DRUG

Dipyrone

Dipyrone 1 tablet twice a day

OTHER

Dipyrone placebo

Placebo of dipyrone 1 tablet twice a day

DRUG

Tramadol hydrochloride

Tramadol 1 coated tablet twice a day

OTHER

Tramadol hydrochloride placebo

Placebo of tramadol 1 coated tablet twice a day

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY

NCT05125978 - Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain | Biotech Hunter | Biotech Hunter